Skip to main content

Advertisement

Table 2 Meta-regression analyses on FMD in patients with type 2 diabetes

From: Exercise training and endothelial function in patients with type 2 diabetes: a meta-analysis

Variables All exercise Aerobic exercise Combined exercise
N β P N β P N β P
Age (log-transformed)a 10 − 0.53 0.72 5 20.1 0.17 4 − 0.06 0.97
Disease durationa 6 − 0.03 0.82 3 − 0.08 0.69 2 NA NA
Training duration 10 − 0.10 0.26 5 NA NA 4 − 0.13 0.17
Proportion of malesa 10 0.01 0.50 5 − 0.04 0.20 4 0.06 0.28
Baseline dataa
 FMD at baseline 9 0.43 0.23 5 1.33 0.29 3 1.16 0.48
 Body mass index 10 − 0.16 0.34 5 − 0.30 0.19 4 − 0.32 0.34
 Systolic blood pressure 6 0.03 0.70 4 − 0.10 0.34 2 NA NA
 Diastolic blood pressure 6 0.01 0.95 4 0.41 0.30 2 NA NA
 Mean arterial pressure 7 0.23 0.05 4 − 0.19 0.76 3 0.20 0.28
 Fasting blood glucose 6 0.17 0.73 4 − 0.71 0.29 2 NA NA
 Hemoglobin A1c 10 1.11 0.09 5 − 1.97 0.44 4 1.21 0.17
 Peak oxygen consumption 8 − 0.01 0.95 3 − 3.27 0.61 4 − 0.03 0.95
Change scores post-exercise interventionb
 Body mass index 6 − 2.10 0.55 3 − 4.64 0.57 3 3.60 0.59
 Systolic blood pressure 6 − 0.16 0.30 4 − 0.20 0.28 2 NA NA
 Diastolic blood pressure 6 − 0.10 0.55 4 − 0.22 0.35 2 NA NA
 Fasting blood glucose 5 1.44 0.62 4 − 4.66 0.34 1 NA NA
 Hemoglobin A1c 9 − 2.52 0.24 5 − 5.02 0.12 3 1.96 0.73
 Peak oxygen consumption 6 − 0.38 0.74 3 1.14 0.55 3 − 1.40 0.52
  1. FMD flow-mediated dilation, NA not applicable
  2. a They were the baseline mean values of intervention and control groups
  3. b They were the average change cores from baseline between intervention and control groups except the study by Maiorana and colleague [21]